Related terms
- Dementia
- An umbrella term for a decline in memory and thinking severe enough to interfere with daily life. Alzheimer’s disease is the most common cause.
- Montreal Cognitive AssessmentMoCA
- A 30-point screening test of memory, attention, language and reasoning, widely used to detect mild cognitive impairment. Higher scores indicate better performance.
- Cognitive decline
- A fall in memory, attention or reasoning skills. Some decline is a normal part of aging, and a faster or larger decline can signal a condition such as dementia.
Research that mentions mild cognitive impairment
19 studies in our archive have this term in the title. The newest are below.
Home-Based Tailored Light Therapy for Sleep, Mood, and Cognitive Outcomes in Mild Cognitive Impairment: A Randomized Trial
Light exposure was measured as area under the curve (AUC) for morning circadian stimulus (CS).
A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial
Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.
Home-based transcranial photobiomodulation improves cognitive function in mild cognitive impairment due to Alzheimer's disease: A randomized, double-blind, placebo-controlled confirmatory trial
The observed benefits are consistent with enhanced mitochondrial metabolism, cerebral perfusion, and synaptic efficiency.
Effects of bright light therapy on cognition, sleep and psychological stress in older adults with mild-to-moderate cognitive impairment: a pilot study in long-term care facilities
Following a 28-day BLT intervention, participants with MMCI showed a modest increase in MMSE scores and increases in total sleep time and deep sleep time, along with reduced body movement frequency.
The Impact of Transcranial Direct Stimulation Therapy Combined with Intranasal Near-Infrared Stimulation on Cognitive Performance in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Study
Combined tDCS and iNIRS therapy significantly enhances cognitive performance in patients with MCI and mild AD. This synergistic, non-invasive approach may offer a promising therapeutic strategy to delay cognitive decline and reduce care-related burdens.
Improved cognitive function, efficiency, saccadic eye movement, and depressive symptoms in mild cognitive impairment with transcranial photobiomodulation
ConclusionsThese findings provide preliminary evidence that tPBM may effectively improve neuropsychological, physiological, and psychological outcomes in individuals with MCI.
Read this with care
- This entry is general information, not medical advice. See the disclaimer.
- Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
- Found a mistake? Tell us.